A Win For Vaxcyte Inc.
Mon, Oct 24, 2022 at 07:35 PM
Vaxcyte Inc. (PCVX:NASDAQ) soared at $33, a gain of 60.3%. On Mon, Oct 24, 2022, PCVX:NASDAQ touched a New 2-Week High of $33. The stock appeared on our News Catalysts scanner on Mon, Oct 24, 2022 at 06:59 PM in the 'BIOTECH' category. From Mon, Oct 10, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About Vaxcyte Inc. (PCVX:NASDAQ)
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 62.43%
- Vaxcyte Inc. (PCVX:NASDAQ), 60.35%
- Mullen Automotive Inc. (MULN:NASDAQ), 32.94%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 24.76%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 23.13%
- NOVONIX Limited (NVX:NASDAQ), 22.1%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 20.6%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 18.1%
- uCloudlink Group Inc. (UCL:NASDAQ), 16.96%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 16.7%